Ignite Creation Date:
2025-12-24 @ 1:12 PM
Ignite Modification Date:
2025-12-28 @ 5:40 PM
Study NCT ID:
NCT02341495
Status:
TERMINATED
Last Update Posted:
2020-02-27
First Post:
2013-09-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Deferasirox, Cholecalciferol, and Azacitidine in the Treatment of Newly Diagnosed AML Patients Over 65
Sponsor:
Elizabeth Henry
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-02
Start Date Type:
ACTUAL
Primary Completion Date:
2016-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-11
Completion Date Type:
ACTUAL
First Submit Date:
2013-09-26
First Submit QC Date:
None
Study First Post Date:
2015-01-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-01-12
Results First Submit QC Date:
None
Results First Post Date:
2020-02-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-25
Last Update Post Date:
2020-02-27
Last Update Post Date Type:
ACTUAL